Association between COPD exacerbations and lung function decline during maintenance therapy
| dc.contributor.author | Kerkhof, Marjan | |
| dc.contributor.author | Voorham, Jaco | |
| dc.contributor.author | Dorinsky, Paul | |
| dc.contributor.author | Cabrera, Claudia | |
| dc.contributor.author | Darken, Patrick | |
| dc.contributor.author | Kocks, Janwillem WH | |
| dc.contributor.author | Sadatsafavi, Mohsen | |
| dc.contributor.author | Sin, Don D. | |
| dc.contributor.author | Carter, Victoria | |
| dc.contributor.author | Price, David B. | |
| dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
| dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
| dc.date.accessioned | 2020-08-18T10:50:00Z | |
| dc.date.available | 2020-08-18T10:50:00Z | |
| dc.date.issued | 2020-09-30 | |
| dc.description | Acknowledgements: Writing and editorial support was provided by Dr Julia Granerod, supported by the Observational and Pragmatic Research Institute Pte. Ltd (OPRI). Funding: This study was funded by AstraZeneca.Data availability statement: Data may be obtained from a third party and are not publicly available. The dataset supporting the conclusions of this article was derived from the Clinical Practice Research Datalink (www.cprd.com) and the Optimum Patient Care Research Database (www.opcrd.co.uk). The CPRD has broad National Research Ethics Service Committee (NRES) ethics approval for purely observational research using the primary care data and established data linkages. The OPCRD has ethical approval from the National Health Service (NHS) Research Authority to hold and process anonymised research data (Research Ethics Committee reference: 5/EM/0150). This study was approved by the Anonymised Data Ethics Protocols and Transparency (ADEPT) committee – the independent scientific advisory committee for the OPCRD, and the Independent Scientific Advisory Committee (ISAC) for the CPRD. The authors do not have permission to give public access to the study dataset; researchers may request access to CPRD or OPCRD data for their own purposes. Access to CPRD can be made via the CPRD website (https://www.cprd.com/researcher/) or via the enquiries email enquiries@cprd. com. Access to OCPRD can be made via the OCPRD website(https://opcrd.co.uk/our-database/data-requests/) or via the enquiries email info@opcrd.co.uk. The study was designed, implemented, and registered in accordance with the criteria of the European Network of Centres for Pharmacoepidemiology and Pharmacovigilance (EUPAS19879). | en |
| dc.description.status | Peer reviewed | en |
| dc.format.extent | 10 | |
| dc.format.extent | 735809 | |
| dc.identifier | 170264444 | |
| dc.identifier | adacb42d-0564-4392-9e68-8c6239881766 | |
| dc.identifier | 32532852 | |
| dc.identifier | 85086718934 | |
| dc.identifier | 000566530300007 | |
| dc.identifier.citation | Kerkhof, M, Voorham, J, Dorinsky, P, Cabrera, C, Darken, P, Kocks, J WH, Sadatsafavi, M, Sin, D D, Carter, V & Price, D B 2020, 'Association between COPD exacerbations and lung function decline during maintenance therapy', Thorax, vol. 75, no. 9, pp. 744-753. https://doi.org/10.1136/thoraxjnl-2019-214457 | en |
| dc.identifier.doi | 10.1136/thoraxjnl-2019-214457 | |
| dc.identifier.iss | 9 | en |
| dc.identifier.issn | 0040-6376 | |
| dc.identifier.uri | https://hdl.handle.net/2164/14945 | |
| dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85086718934&partnerID=8YFLogxK | en |
| dc.identifier.vol | 75 | en |
| dc.language.iso | eng | |
| dc.relation.ispartof | Thorax | en |
| dc.subject | COPD exacerbations | en |
| dc.subject | COPD pharmacology | en |
| dc.subject | eosinophil biology | en |
| dc.subject | lung physiology | en |
| dc.subject | OBSTRUCTIVE PULMONARY-DISEASE | en |
| dc.subject | IMPACT | en |
| dc.subject | BIOMARKER | en |
| dc.subject | BLOOD EOSINOPHILS | en |
| dc.subject | INHALED CORTICOSTEROIDS | en |
| dc.subject | FEV1 DECLINE | en |
| dc.subject | R Medicine (General) | en |
| dc.subject | Pulmonary and Respiratory Medicine | en |
| dc.subject.lcc | R1 | en |
| dc.title | Association between COPD exacerbations and lung function decline during maintenance therapy | en |
| dc.type | Journal article | en |
Files
Original bundle
1 - 1 of 1
- Name:
- Kerkhof_et_al_BMJ_AssociationBetweenCOPD_VoR.pdf
- Size:
- 718.56 KB
- Format:
- Adobe Portable Document Format
